Originally published In Press as doi:10.1074/jbc.M200089200 on April 5, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22725-22733, June 21, 2002
Structural Characterizations of Fusion Peptide
Analogs of Influenza Virus Hemagglutinin
IMPLICATION OF THE NECESSITY OF A HELIX-HINGE-HELIX MOTIF IN
FUSION ACTIVITY*
Chun-Hua
Hsu
§,
Shih-Hsiung
Wu§¶
,
Ding-Kwo
Chang**, and
Chinpan
Chen

From the
Institute of Biomedical Sciences, Academia
Sinica, Taipei 115, Taiwan, the ¶ Institute of Biological
Chemistry, Academia Sinica, Taipei 115, Taiwan, the
§ Institute of Biochemical Sciences, National Taiwan
University, Taipei 106, Taiwan, and the ** Institute of
Chemistry, Academia Sinica, Taipei 115, Taiwan
Received for publication, January 4, 2002, and in revised form, March 21, 2002
 |
ABSTRACT |
Infection by enveloped viruses initially involves
membrane fusion between viral and host cell membranes. The fusion
peptide plays a crucial role in triggering this reaction. To clarify
how the fusion peptide exerts this specific function, we carried out biophysical studies of three fusion peptide analogs of influenza virus
hemagglutinin HA2, namely E5, G13L, and L17A. E5 exhibits an activity
similar to the native fusion peptide, whereas G13L and L17A, which are
two point mutants of the E5 analog, possess much less fusion activity.
Our CD data showed that the conformations of these three analogs in
SDS micelles are pH-dependent, with higher
-helical contents at acidic pH. Tryptophan fluorescence emission
experiments indicated that these three analogs insert deeper into lipid
bilayers at acidic pH. The three-dimensional structure of the E5 analog
in SDS micelles at pH 4.0 revealed that two segments,
Leu2-Glu11 and
Trp14-Ile18, form amphipathic helical
conformations, with Gly12-Gly13 forming a
hinge. The hydrophobic residues in the N- and C-terminal helices form a
hydrophobic cluster. At neutral pH, however, the C-terminal helix of
Trp14-Ile18 reduces dramatically, and the
hydrophobic core observed at acidic pH is severely disrupted. We
suggest that the disruption of the C-terminal helix renders the E5
analog fusion-inactive at neutral pH. Furthermore, the decrease of the
hinge and the reduction of fusion activity in G13L reveal the
importance of the hinge in fusion activity. Also, the decrease in the
C-terminal helix and the reduction of fusion activity in L17A
demonstrates the importance of the C-terminal helix in fusion activity.
Based on these biophysical studies, we propose a model that illustrates
the structural change of the HA2 fusion peptide analog and explains how
the analog interacts with the lipid bilayer at different pH values.
 |
INTRODUCTION |
Membrane fusion plays a vital role in a large and diverse number
of essential biological processes. For example, infection by enveloped
viruses involves fusion of viral and cellular membranes with subsequent
transfer of viral genetic material into the cell. Hemagglutinin
(HA)1 is a homotrimeric
surface glycoprotein of the influenza virus with a relative molecular
mass of 220 kDa. Each monomer of HA consists of the receptor-binding
HA1 domain (328 residues) and the membrane-interacting HA2 domain (221 residues) linked by a single disulfide bond. The membrane fusion
activity of HA has been measured both in vivo and in
vitro by a variety of techniques, including hemolysis (1),
polykaryon formation (2), resonance energy transfer (3), liposome cell
fusion (4), spin-labeled electron paramagnetic resonance (5), electron
microscopy (6), flow cytometry (7), electron spin resonance, and
Fourier transform infrared (8). The N-terminal 20 residues of the HA2
domain have been identified as the fusion peptide, which is capable of inserting into the target membrane and thereby plays a crucial role in
triggering membrane fusion. The crystal structure of soluble trimers
(BHA) at neutral pH, in which each HA2 chain after residue 175 is cleaved, revealed that the fusion peptide is buried inside the
protein (9). In the crystal structure study, TBHA2 was prepared by successive digestion with trypsin and thermolysin from BHA
at pH 5.0. Each monomer of TBHA2 consists of residues 38-175 of the HA2 chain and residues 1-27 of the HA1 chain linked by
a disulfide bridge, and the fusion peptide becomes exposed to the
aqueous phase in the crystal structure of TBHA2 (10). The
difference in the location of the fusion peptide between BHA and
TBHA2 accounts for the membrane fusion induction between
viral and endosomal membranes occurring at acidic pH for HA.
A comparison of the fusion peptide sequences (20 amino acids) in
various subtypes of influenza virus A strains (11, 12) demonstrated
that residues Gly1-Glu11, Gly13,
Trp14, and Gly16 are
conserved. Also, Gly20
is rather conserved with only one exception of Val20 in the
A/duck/Hong Kong/231/77 virus strain. Position 12 includes either Gly
or Asn, position 17 includes either Met or Leu, and position 18 includes either Ile or Val. Thus, the native fusion peptide of the
influenza HA2 is highly hydrophobic, extremely aggregative, and hardly
soluble in aqueous solution. The fusion activities of several HA2
fusion peptide mutants have been extensively studied. For example, the
fusion peptide without its C-terminal residues 17-20 was fusogenicity
inactive (13). Replacement of Glu11 with Pro11
resulted in a marked decrease in
helical content, concomitant with
an almost complete loss of fusogenicity (14). Replacing the N-terminal
Gly1 with Glu1 eliminated viral fusion activity
(15), but the fusion activity stayed the same with a Gly1
Ala1 substitution (16). Mutational studies of the
fusion activity for the two Ala residues in the N terminus showed that
Ala5 tolerated a smaller (Gly) hydrophobic side chain and
that Ala7 tolerated a larger (Val) hydrophobic side chain
(17). A negatively charged E5 analog was found to possess fusion
activity at acidic pH (14, 18), similar to that of the native fusion
peptide. In addition to triggering fusion activity, the E5 analog has
also been found to promote antisense the entrance of oligonucleotides into the cytosol of mammalian cells upon permeabilization of the plasma
membrane (19). The specific angle of insertion of the peptide into the
membrane plane was observed to be an important characteristic for the
fusion process for both intact and synthetic fusion peptides (8,
20).
To date, structural studies of the membrane-bound state of the HA2
fusion peptide and of its analogs have been performed using several
biophysical techniques. Upon binding to synthetic liposomes or lipids,
the native fusion peptide and its analogs possess higher
-helical
contents (18, 21). The NMR solution structures of the native fusion
peptide with a host-guest system of influenza hemagglutinin (22) and of
the E5 peptide in dodecylphosphocholine (DPC) micelles (23) have been
determined. In the present study, we applied fluorescence, CD, and NMR
methods to carry out biophysical studies in SDS micelles for the E5
analog and its two point mutants, G13L and L17A (Table I), both of
which possess much less fusion activity than the E5 analog (12). We
then developed a model that describes the structural change of the
fusion peptide analog and how the analog interacts with the lipid
bilayer at different pH values, on the basis of the determined
three-dimensional structures and results from CD and fluorescence
experiments. Comparison of our model with the two recently reported
models (22, 23) is then discussed.
 |
EXPERIMENTAL PROCEDURES |
Sample Preparation--
Three fusion peptide analogs of HA2 of
virus strain A/PR/8/34 (8), E5 and its two point mutants, G13L and
L17A, were synthesized in automated mode by a solid phase synthesizer
(model 431 A; Applied Biosystems, Foster City, CA). These synthetic
peptides were cleaved from the resins with trifluoroacetic acid and
purified by reverse-phase high pressure liquid chromatography. The
sequences of these peptides were ascertained by electrospray mass
spectrometry and by amino acid analysis. Deuterated SDS was purchased
from Cambridge Isotope (Woburn, MA). Unless otherwise specified, all of
the reagents and solvents were obtained commercially of reagent grade
and used without further purification.
CD Experiments--
CD experiments were collected using an AVIV
CD 202 spectrometer (AVIV, Lakewood, NJ) calibrated with
(+)-10-camphorsulfonic acid at 25 °C. In general, a 2-mm path-length
cuvette with 50 µM (or 20 µM) fusion
peptide analog in 20 mM phosphate was used for CD
experiments. The CD spectra of each analog at a molar ratio of 1:100
(peptide/SDS) at different pH values (pH 3.5-9.0) were recorded. Each
of the CD data was obtained from an average of three scans with 1-nm
bandwidth. The spectra were recorded from 180 to 260 nm at a scanning
rate of 38 nm/min with a wavelength step of 0.5 nm and a time constant
of 100 ms. After background subtraction and smoothing, all of the CD
data were converted from CD signal (millidegree) into mean residue
ellipticity (deg cm2 dmol
1). The secondary
structure content of each peptide was estimated from the CD spectra
according to the method of Sreerama and Woody (24).
Fluorescence Measurements--
Penetration of fusion peptides
into membranes can be determined by monitoring changes in intrinsic
fluorescence of aromatic amino-acids (Trp, Tyr, or Phe) contained in
the peptide sequence. All of the fluorescence experiments were
performed on a Hitachi F-4010 fluorescence spectrofluorometer at
ambient temperature. An excitation wavelength of 280 nm was used to
record spectra from 290 to 490 nm with a data interval of 1 nm. The
response time was set at 2 s with a scan rate of 60 nm·min
1. Excitation and emission slits of 5 and 1.5 nm,
respectively, were used for measurements in the presence and absence of
SDS micelles. Acrylamide was used for tryptophan fluorescence quenching experiments. An incremental amount of acrylamide stock solution (1 M) was added to the peptide (10 µM) solutions
to make final concentrations of acrylamide up to 50 mM in
the presence of SDS micelles at pH 4.3 and 7.3. The data were analyzed
according to the following Stern-Volmer equation (25).
|
(Eq. 1)
|
Where F0 and F are the
fluorescence intensities in the absence and the presence of quencher
[Q], respectively. KSV, calculated as the
slope of the Stern-Volmer plot, is the Stern-Volmer quenching constant
and is a measure for the accessibility of the tryptophan to acrylamide.
NMR Experiments--
NMR measurements were carried out on a
Bruker AMX-500 or an AVANCE-600 spectrometer. The samples for the NMR
experiments contained about 0.35 ml of 2 mM peptide in SDS
micelles (peptide/SDS 1:100) using 20 mM phosphate buffer
to adjust pH values (pH 4.0-9.0). pH values were measured with a
dissolved oxygen microelectronic pH vision model PHB-9901 pH meter
equipped with a 4-mm electrode. All of the reported pH values were
direct readings from the pH meter without correction for the isotope
effect. To monitor the exchange rates of labile protons, the
concentrated sample in H2O was lyophilized only once and
redissolved in D2O (99.99% D). The NMR spectra were
acquired immediately and thereafter at appropriate time intervals. All
of the chemical shifts were externally referenced to the methyl
resonance of 2,2-dimethyl-2-silapentane-5-sulfonate (0 ppm). Double
quantum filtered scalar-correlated spectroscopy (26), total correlation
spectroscopy (27), and NOESY (28) were collected with 512 t1 increments with 2K complex data points. All
spectra were recorded in time-proportioned phase increment mode (29).
The titration experiments of the chemical shift versus pH
were carried out using one- and two-dimensional NMR experiments at 310 K for E5 and G13L. The titration experiment was not performed for L17A,
because of its severe precipitation at neutral pH. Low temperature
studies employed a temperature-controlled stream of cooled air using a
Bruker BCU refrigeration unit and a B-VT 2000 control unit. Water
suppression was achieved by 1.4 s of presaturation at the water
frequency or by the gradient method (30). All spectra were collected
with 6024.1- and 7788.16-Hz spectral widths for AMX-500 and AVANCE-600, respectively.
The data were transferred to an SGI O2 work station (200 MHz R5000SC; Silicon Graphics, CA) for the processing and further analysis using Bruker XWINNMR and AURELIA software packages (Karlsruhe, Germany). All data sets acquired were zero-filled to equal points in
both dimensions prior to further processing. A 60°-shifted skewed
sine bell window function was applied in all NOESY and total
correlation spectroscopy spectra, and a 20°- or 30°-shifted skewed
sine bell function was used for all correlated spectroscopy spectra. To
help resolve spectral overlap, the data were collected at different temperatures.
Structure Calculations--
Distance restraints of fusion
peptide analogs were derived primarily from the 200-ms NOESY spectrum
recorded in SDS micelles at 310 K, pH 4.0. Comparison was made to the
100-ms NOESY spectrum to assess possible contributions from spin
diffusion. Peak intensities were classified as large, medium, small,
and very small, corresponding to the upper bound interproton distance
restraints of 2.5, 3.5, 4.5, and 6.0 Å, respectively. An additional
correction of 1.0 Å was added for methylene and methyl groups.
Backbone dihedral restraints were inferred from
3JNH coupling constants, with
restrained to
120 ± 30° for 3JNH
> 8Hz and
60 ± 30° on 3JNH
< 6Hz.
Three-dimensional structures were generated using a simulated annealing
and energy minimization protocol in the program X-PLOR 98 (31).
Hydrogen bond restraints were included only in the final stage of
refinement, and all of the peptide bonds were defined as
trans. Average structures were calculated using the final
set of refined structures and were further energy minimized to ensure
correct local geometry. The INSIGHT II (Molecular Simulation Inc., San
Diego, CA), MOLMOL (32), and GRASP (33) software programs were used to
visualize sets of structures and to calculate and draw the
electrostatic surface potential of the final three-dimensional models.
The convergence of the calculated structures was evaluated in terms of
the structural parameters, that is, the root mean square deviation from
the experimental distance and dihedral constraints, the values of the
energy statistics (Fnoe,
Ftor, and Frepel), and
the root mean square deviation from the idealized geometry. The
distributions of the backbone dihedral angles of the final converged
structures were evaluated by the representation of the Ramachandran
dihedral pattern, indicating the deviations from the sterically allowed
(
and
) angle limits using PROCHECK-NMR (34).
 |
RESULTS |
Conformational Changes at Different pH Values--
CD spectroscopy
was used to determine whether the peptides undergo a conformational
change upon interaction with lipid micelles at different pH values. The
CD spectra of three analogs at various pH values in SDS micelles all
showed that the conformations of the analogs are
pH-dependent (Fig. 1). The
observations of 208- and 222-nm negative ellipticities and of
isodichroic point at 203, 203, and 204 nm for E5, G13L, and L17A,
respectively, revealed that a random coil and an
-helix are in
equilibrium in these analogs. Based on the standard values of the mean
residue molar ellipticity at 222 nm, 4000 deg cm2
dmol
1 for the random coil and
38000 deg cm2
dmol
1 for the
-helix (35), we estimated the following
-helical content for each analog at pH 7.0 and 3.5, respectively: 48 and 72% for G13L; 43 and 62% for E5; and 24 and 43% for L17A.
Clearly, G13L exhibits the highest content of
-helical structures,
whereas L17A contains fewest
-helical structures at both neutral and fusogenic pH. At pH > 6.0, the negative ellipticity shifted to the value of ~200 nm in L17A, indicating that L17A is mostly
unstructured under this condition. Interestingly, the helical content
of L17A at acidic pH is nearly the same as that of E5 at neutral
pH.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
CD spectra of E5 (A), G13L
(B), and L17A (C) analogs at
different pH values in SDS micelles with a molar ratio of peptide/SDS
of 1:100 at 25 °C are shown. The isodichroic point at 203, 203, and 204 nm for E5, G13L, and L17A, respectively, was observed,
indicating that an -helix and a random coil are in equilibrium in
these analogs.
|
|
Depth of Tryptophan Penetration to Membrane--
All three analogs
contain a Trp residue at position 14. To verify the interaction of the
fusion peptide analogs and the SDS micelles, the steady-state
fluorescence emission spectra of these three analogs were measured. It
is suggested that the observation of a blue shift upon interaction of
the peptides with the negatively charged vesicles indicates that the
tryptophan moiety has penetrated into the vesicle bilayer. As shown in
Fig. 2A, the E5 peptide at
neutral pH without SDS micelles exhibited a emission maximum at 352 nm
and reached a maximum of 336 nm in the presence of SDS micelles. This
observation of a blue shift verifies the transfer of tryptophan to a
more hydrophobic environment and verifies that there is an interaction
between the E5 analog and micelles. At acidic pH, a further blue shift
was observed, indicating a deeper insertion of tryptophan into lipid
bilayers. Interestingly, G13L possesses characteristics in its
fluorescence data very similar to those of the E5 peptide (Fig.
2B). The fluorescence spectra of L17A shown in Fig.
2C, however, revealed a different characteristic. The
emission maximum of L17A remained at ~352 nm in aqueous solution with
or without micelles at neutral pH, revealing that at neutral pH it
hardly interacts with micelles. At acidic pH the emission maximum
shifted to 336 nm, the same as the maximum of E5 at neutral pH. The
result of fluorescence emission experiments seems to indicate that the
structure of E5 at neutral pH is quite similar to that of L17A at
acidic pH. To further verify that tryptophan inserts deeper into lipid
bilayers at acidic pH, we carried out acrylamide fluorescence quenching
experiments. Fig. 3A shows the
Stern-Volmer plot for E5, G13L, and L17A peptides in SDS micelles at pH
4.3 and 7.3. A comparison of the Stern-Volmer quenching constants (M
1) among these peptides is shown in Fig.
3B. The three analogs at acidic pH all possess a smaller
KSV value compared with that at neutral pH,
indicating that the Trp residue inserts deeper into lipid bilayers at
acidic pH. In addition, the KSV value of E5
peptide at neutral pH is nearly identical to that of L17A at acidic pH,
in good agreement with the finding that the emission maximum of E5 at
neutral pH is the same as that of L17A at acidic pH.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Fluorescence emission spectra of E5
(A), G13L (B), and L17A
(C) acquired in the absence and presence of SDS
micelles at different pH values. For clarity, the emission maximum
at three different conditions for each analog is indicated by a
labeled arrow. Arrow a, in the aqueous solution
at pH 7.0; arrow b, in the presence of SDS micelles at pH
7.0; arrow c, in the presence of SDS micelles at pH
3.5.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Trp fluorescence quenching experiments of HA2
fusion peptide analogs by acrylamide in the presence of SDS micelles
are shown. A, Stern-Volmer plots for E5, G13L, and L17A
peptides in SDS micelles at pH 4.3 and 7.3. The peptide concentration
is 10 µM and acrylamide concentration is given on the
x axis. B, a comparison of the Stern-Volmer
quenching constants (M 1) for E5, G13L, and
L17A in the presence of SDS micelles at pH 4.3 and 7.3.
|
|
Resonance Assignments and Secondary Structure
Determination--
With well dispersed NMR data, resonance assignments
for E5, G13L, and L17A were accomplished using standard procedures. The total correlation spectroscopy and double quantum filtered
scalar-correlated spectroscopy spectra were used to assign the spin
systems, and the NOESY spectra were used to make sequential connections
between spin systems. In addition, the NMR experiments obtained at
different temperatures (285, 295, and 310 K) at both neutral and
fusogenic pH values were used to assign the overlapping peaks. Fig.
4 shows the representative regions of the
NOESY spectra involving the backbone protons for E5, G13L, and L17A at
pH 4.0, respectively. In general, the observations of weaker
d
N(i, i+1) and stronger d
N(i, i) and
dNN(i, i+1)
connectivities, together with
d
N(i, i+3),
d
N(i, i+4), and
d
(i, i+3) NOEs,
suggest a stabilization of the
-helical structure. We observed a set
of
-helical NOEs in the N-terminal segment of
Ile2-Glu11 for all three analogs at acidic pH.
In the C-terminal region, the absence of d
N
(10, 13) NOE and the observation of a nonhelical medium range NOE
of d
(9, 13) indicated the lack of an
-helix in the E5 analog in the Gly12-Gly13
dipeptide. In the Trp14-Ile18 segment of E5,
the weaker intensities of d
(14, 17), d
(15, 18), d
N
(14, 17), and d
N (15, 18) NOEs indicate that
this region possesses some
-helical structures but that it is less
populated than the N-terminal
-helix. Compared with the
C-terminal structure of the E5 peptide, structural differences were
seen in the C-terminal regions in G13L and L17A, both of which possess
much less fusion activity than E5. In G13L, neither
d
(9, 13) nor d
N
(9, 13) NOEs were found, and two intensive
-helical NOEs,
d
N (10, 13) and d
N
(13, 16), were identified instead, indicating that a replacement of
Gly13 with Leu13 (G13L) increased the
-helical conformation in residues 12-13. Further, based on the
presence of stronger
-helical NOEs in the C terminus than those
present in the C terminus of E5, we concluded that G13L possesses
higher C-terminal
-helical contents than the E5 peptide. Therefore,
the G13L analog likely forms an extended helix. In contrast, the NMR
data of L17A at acidic pH show that its C-terminal
-helix almost
disappears with very small d
N (14, 17),
d
(14, 17), and
d
(15, 18) NOEs and the disappearance of
the d
N (15, 18)
-helical NOE in
Trp14-Ile18. A comparison of NOEs between E5
and L17A, however, does not show any significant change in the
N-terminal
-helix and the hinge region. Consequently, the main
structural difference between E5 and L17A comes from the C-terminal
-helix in the Trp14-Ile18 segment. Fig.
5 shows a comparison of the
C
H chemical shift between E5 and G13L and between E5 and
L17A, respectively. The substitution of Leu for Gly13
(G13L) lowers the C
H chemical shifts in its neighboring
residues (Ile10-Gly12 and Trp14),
revealing that the segment of Ile10-Trp14 in
G13L contains a higher propensity to form a helical structure. The
substitution of Ala for Leu17 (L17A), however, increases
the C
H chemical shift at residues Trp14 and
Glu15, indicating a reduction in the C-terminal helix.
Thus, the derived secondary structures based on NOE connectivities and
C
H chemical shifts are in good agreement. At neutral pH,
the N-terminal
-helix remains and the C-terminal
-helix of E5 is
dramatically reduced, as deduced by the disappearance or significantly
less intensity of medium
-helical NOEs:
d
(14, 17), d
(15, 18), d
N (14, 17), and
d
N (15, 18). Therefore, the pH-induced
structural change of the E5 peptide at different pH values is mainly
due to the C-terminal
-helix. To check the rigidity of the structure
and to identify the hydrogen bonds, we measured the amide-proton
exchange rates for these analogs in SDS micelles using one- and
two-dimensional NMR for E5, G13L, and L17A at acidic pH. The N-terminal
amide protons (Ala5-Ile10) were still
present in all three analogs after dissolution in D2O for
more than 30 min, suggesting that these residues are likely to form
strong hydrogen bonds. Thus, the exchange rates show that the
N-terminal
-helix in these three analogs is more stable and rigid
than the C-terminal one. The 3JNH
coupling
constants estimated from the two-dimensional double quantum filtered
scalar-correlated spectroscopy spectra imply that N-terminal residues
Leu2-Glu11 possess smaller coupling constants
(< 6Hz), which is in agreement with the formation of an
-helix in
this region. Fig. 6 provides an NMR
summary for these three analogs, respectively. All of the NMR
parameters support that E5 forms a stable
-helical structure in
Leu2-Glu11 and a loose
-helix in the C
terminus at Trp14-Ile18, with
Gly12-Gly13 forming a hinge. G13L extends the
N-terminal helix to the C-terminal region, and L17A nearly loses the
C-terminal short helix entirely.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 4.
The fingerprint and HN/HN regions of NOESY
spectra of E5 (A), G13L (B), and L17A
(C) in SDS micelles at pH 4.0 and 310 K. The
sequential connectivities are annotated, and the intraresidue NOEs in
the fingerprint region are indicated with a one-letter amino acid code
and a residue number. The observation of d N
(10, 13) NOE and the disappearance of d N (9,
13) in G13L are specifically indicated by arrows. The two
-helical NOEs, d N (14, 17) and
d N (15, 18) in L17A, which were hardly seen,
were also indicated by arrows.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Comparisons of the
C H chemical shift of G13L and E5
(A) and L17A and E5 (B) are
shown. The substitution of Leu for Gly13 (G13L) lowers
the C H chemical shift in its neighboring residues
(Ile10-Gly12 and Trp14), revealing
that this segment contains a higher propensity to form a helical
structure. However, the substitution of Ala for Leu17
(L17A) increases the C H chemical shift at residues
Trp14 and Glu15, indicating a reduction of the
C-terminal -helix.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Summaries of the amide proton exchange rates,
the 3JNH coupling
constants, NOE connectivities, and
C H chemical shift index for E5,
G13L, and L17A at pH 4.0 are shown. Slow and medium exchanging
amide protons are represented by filled and open
circles, respectively. The 3JNH
coupling constants smaller than 6 Hz are indicated by filled
squares. Bar thickness indicates the intensity of NOE
connectivity, with thicker bars representing stronger NOEs.
Negative bars in the chemical shift index indicate upfield
shifts of more than 0.1 ppm of the C H compared with the
expected random coil C H chemical shift. Positive
bars indicate downfield shifts of more than 0.1 ppm of the
C H compared with the expected random coil
C H value.
|
|
Analysis of pH Titration Experiments--
On the basis of the
titration curves of the chemical shift versus pH, we
determined the pKa values of five Glu residues in
the sequence (Glu4, Glu8, Glu11,
Glu15, and Glu19) of E5 and G13L peptides in
SDS micelles. We found that they are nearly identical to the values in
DPC micelles reported by Dubovskii et al. (23). In addition,
the chemical shift change for the C
H of
Ile10 and Glu15 of E5 peptide in these two
micellar solutions at different pH values are also very similar.
However, in G13L, we only observed very small chemical shift changes of
Glu15 C
H and did not detect any shift change
of Ile10 C
H at different pH values.
Evidently, the backbone structure at Ile10 and its nearby
region of G13L is very rigid and pH-independent.
Tertiary Structures--
Because E5 possesses membrane-penetrating
activity similar to the native fusion domain (36), we first determined
the E5 structure in SDS micelles at fusogenic pH. A set of 372 restraints was used for simulated annealing and energy minimization
calculations using the software program X-PLOR. Among these restraints,
356 are interproton distance restraints, 10 are hydrogen bond
restraints, and 6 are dihedral-angle restraints. Each structure was
checked according to geometric deviation, total energy, and distance
violation. Thirteen structures were chosen to represent the ensemble of
NMR structures on the basis of the lowest target function and minimal distance and torsional angle restraint violations in the final stage.
All of these structures were consistent with both experimental data and
standard covalent geometry and displayed no violations greater than 0.5 Å for distance restraints. The NMR solution structures demonstrate
that the E5 peptide is composed of two helical segments; one section is
located in the N terminus (residues
Leu2-Glu11), and the other is located in the
C-terminal region (Trp14-Ile18). In the
C-terminal Trp14-Ile18 segment, the backbone
and
dihedral angles are close to the values for
310-helix (
=
60° and
=
30°) and
two (i, i+3) hydrogen bonds, Trp14
CO/Leu17 NH and Glu15 CO/Ile18 NH,
were observed; thus it is confirmed that
Trp14-Ile18 forms a 310-helix. Gly
is known to be a helix-breaking residue. As expected,
Gly12-Gly13 terminates the N-terminal
-helical structure and forms a hinge structure. For clarification,
superimpositions of backbone heavy atoms (N, C
, and C') from
residues 2-18, 2-11, and 14-18 with root mean square deviations of
1.26, 0.44, and 0.29 Å, respectively, were calculated and are shown in
Fig. 7. The precise orientation of the
two helical segments could not be determined because of the lack of
medium and long range NOEs between the two helices. An angle between
the two helical axes of ~120° was consistently observed in the
ribbon representation of structure. The structural statistics on the
final set of structures are given in Table
II. Interestingly, because of the
twist of the central hinge in E5, the charge distribution of E5 forms
an amphipathic bent helical structure with five negatively
charged Glu residues located on one side and with the hydrophobic
residues located on the opposite side (Fig.
8). Using the same protocol, we also
generated the solution structures of G13L and L17A at acidic pH. A
comparison of the ribbon diagrams of the three analogs is shown in Fig.
9.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Superposition of the backbone (N,
C , and C') atoms of 13 NMR
structures of the E5 analog obtained from simulated annealing and
energy minimization calculations. The structures are best fitted
to residues 2-18 (A), 2-11 (B), and 14-18
(C), respectively.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 8.
The active fusion peptide analog E5 presents
a helix-hinge-helix structural motif. A, a cartoon
representation of the structure of the E5 analog at fusogenic pH, with
a helix-hinge-helix structural motif. B, the hinge
structure of the E5 analog facilitates the hydrophobic surface of the
C-terminal helix to twist to the same side with the hydrophobic surface
of the N-terminal -helix. The helix-hinge-helix structure of E5
forms a hydrophobic pocket consisting of Leu2,
Phe3, Ile6, Phe9,
Ile10, Trp14, Leu17, and
Ile18.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 9.
A comparison of ribbon diagrams of the
three-dimensional structures of E5, G13L, and L17A analogs is
shown. The ribbon structure was produced using the MOLMOL
program.
|
|
 |
DISCUSSION |
We performed CD, fluorescence, and NMR experiments to investigate
the structural changes of three fusion peptide analogs of influenza
virus HA2 in SDS micelles at different pH values. As described above,
E5 possesses fusion activity similar to the native fusion peptide,
whereas G13L and L17A exhibit much less fusion activity than the E5
analog. CD experiments revealed that G13L possesses higher
-helical
content than E5 at acidic and neutral pH, indicating that
-helical
structure alone cannot cause fusion activity for influenza HA2 fusion
peptide. Both E5 and G13L showed a blue shift in their fluorescence
spectra in the presence and absence of SDS micelles at neutral pH,
revealing that both analogs penetrate into the micelles and associate
with the hydrophobic core in the lipid bilayer at neutral pH. In
contrast, the emission maximum of fluorescence spectra of L17A at pH
7.0 remained the same with or without SDS micelles, indicating that SDS
micelles are unable to induce any conformational change in L17A at
neutral pH. This observation is consistent with our CD data, which show that at neutral pH L17A is mostly unstructured in the presence of SDS
micelles and in the aqueous solution. From neutral to acidic SDS
micelles, a further blue shift was detected in E5 and G13L, indicating
a deeper insertion of both analogs into lipid bilayers. Also, a blue
shift of 16 nm (shift from 352 nm to 336 nm) observed in L17A suggested
that L17A can penetrate into and interact with the micelles at acidic
pH. It is noteworthy that the emission maximum of L17A at acidic pH is
the same as that of E5 at neutral pH. Therefore, the characteristic of
E5 of peptide insertion into lipid bilayers at neutral pH should be
similar to that of L17A at acidic pH. Acrylamide quenching experiments
showed that the KSV values for E5, G13L, and
L17A at acidic pH are lower than the KSV values
at neutral pH in the presence of SDS micelles, indicating that the
tryptophan residue is more protected against quenching by acrylamide at
acidic pH. Accordingly, fluorescence emission experiments revealed that
E5 as well as G13L exhibit a very similar means for peptide insertion
into lipid bilayers, even though they possess different fusion
activities. This phenomenon indicates that the insertion of a peptide
into lipid bilayers does not guarantee whether the peptide is
fusion-active.
The NMR solution structure of the E5 peptide in SDS micelles at pH 4.0 is comprised of a regular
-helix in the N-terminal Ile2-Glu11 and a 310-helix in the
C-terminal Trp14-Ile18, with
Gly12-Gly13 forming a hinge. Also, the
hydrophobic residues in the N- and C-terminal helices form a
hydrophobic cluster. We suggest that the fusion peptide inserts into
the lipid bilayers with its hydrophobic surface exposed to the apolar
interior of the membrane. At neutral pH, the pH-induced structural
change of the E5 analog occurs predominantly in the C-terminal helix.
The decrease of the C-terminal helix hence breaks the hydrophobic
cluster observed at acidic pH, and the fusion activity becomes
inactive. A comparison of the solution structures of E5 and G13L shows
that the hinge observed in E5 is dramatically reduced in G13L at acidic
pH. The decrease of the hinge along with the reduction of fusion
activity in G13L reveals the importance of the hinge in fusion
activity. By contrast, we found that the main structural difference
between E5 and L17A at acidic pH occurs at the C-terminal helix.
Therefore, the decrease of the C-terminal helix together with the
reduction of fusion activity in L17A demonstrates the importance of the
C-terminal helix in fusion activity. Taken together, the structural
features that are essential for fusion activities of the influenza
fusion peptide can be summarized as follows: 1) a rigid N-terminal
helix for disrupting the membrane, 2) a central hinge for twisting and bending N- and C-terminal helices to form a hydrophobic cluster, and 3)
a C-terminal 310-helix to span the membrane, thereby
facilitating deeper insertion of the peptide and formation of a central
hinge at acidic pH.
Taking these results together, we propose a model (Fig.
10) to describe the structural change
of the E5 analog and how E5 interacts with the lipid bilayer at
different pH values. At neutral pH, a blue shift was observed for the
E5 analog in the presence and absence of SDS micelles, implying that
there is an interaction between the Trp residue and the lipid bilayer.
We thus suggest that Gly1-Trp14 is located
inside the membrane, with Trp14 near the head group of the
lipid bilayer, and that the C-terminal region
(Glu15-Gly20) is exposed to the aqueous phase.
When lowering the pH, the charged residues, Glu11 and
Glu15, are neutralized, and the C-terminal helix is
increased. Under this condition, Glu15-Ile18
also inserts into lipid bilayers, and a hydrophobic core is formed among the hydrophobic residues in the N- and C-terminal helices to
facilitate the interaction of the E5 analog with the lipid bilayer. The
fusion peptide analog then destabilizes the membrane, with the fusion
pore forming with the help of the hinge in the Gly12-Gly13 dipeptide, thereby triggering
membrane fusion.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 10.
A proposed model, based on the results from
NMR, CD, and fluorescence experiments, shows the structural change of
the E5 analog and how the analog interacts with lipid bilayers at
different pH values. The C terminus is mostly unstructured at high
pH and is exposed in the aqueous phase. At fusogenic pH, the helical
content in Trp14-Ile18 is increased because of
the charge neutralization on Glu15 and/or
Glu11. The C-terminal helix then penetrates into the
membrane and interacts with the hydrophobic core in the lipid bilayer.
In the meantime, the flexible region in
Gly12-Gly13 serves to facilitate fusion pore
formation. Subsequently, the fusion peptide analog destabilizes the
membrane and then triggers membrane fusion.
|
|
Our proposed model is different from the reported model (23) based on a
structural study of the E5 peptide in DPC micelles. The CD spectra
showed that the E5 peptide in DPC micelles contains more helical
content (50%) at pH 5.4 than at pH 6.7 (40%), which is in good
agreement with our finding that the conformation of the E5 peptide in
SDS micelles is pH-dependent. The NMR solution structure of
the E5 analog in DPC micelles at pH 5.4 and at a detergent-to-peptide
ratio of 60 was determined to contain an amphipathic
-helix in
residues 2-18, in which 11-18 is flexible. However, the hinge in
Gly12-Gly13 dipeptide and pH-induced structural
change in the C-terminal helix were not mentioned in the paper.
Dubovskii et al. (23) then used the plot of the chemical
shift versus pH to determine the pKa
values of five Glu residues in the sequence, and Glu11 and
Glu15 were shown to possess unusually high
pKa values of ~5.6 compared with a
pKa of 4.24 for isolated glutamic acid in aqueous
solution. Based on these elevated pKa values, the
proposed model of Dubovskii et al. shows that fusion
activity is likely driven by the protonation of the carboxylate group
of the Glu11 residue participating in a transient hydrogen
bond with the backbone amide proton of Glu15. According to
the model, once the side chain carboxylate of Glu11 is
protonated at acidic pH (pH < 6), the fusion peptide relocates into the hydrophobic core of the micelle followed by stabilization of
the amphipathic
-helix in residues 2-18. Interestingly, we found
that the pKa values of five Glu residues in the sequence (Glu4, Glu8, Glu11,
Glu15, and Glu19) of E5 and G13L peptides in
SDS micelles are nearly identical to the values in DPC micelles
reported by Dubovskii et al. This finding indicates that
possessing unusual pKa values in the
Glu11 and Glu15 residues is not the only factor
for the HA2 fusion peptide in fusion activity, because G13L is much
less fusion-active than E5. In addition, we did not observe the
hydrogen bond between the carboxylate group of Glu11 and
the backbone HN of Glu15 in our NMR structures
of the E5 analog in SDS micelles. Apparently, the proposed model of
Dubovskii et al. contradicts our biophysical data. In
contrast, our model is similar to the one proposed by Han et
al. (22). The solution structure of influenza HA2 host-guest fusion domain was determined to contain the structural motifs of
helix-break-helix and helix-break-irregular at pH 5.0 and 7.4, respectively. Both structures are highly amphipathic and feature a bend
in the middle, and this bend orients the two ends of the fusion domains
toward their hydrophobic faces. Strikingly, the structural basis
between native fusion peptide in DPC micelles and the E5 analog in SDS
micelles at different pH values are almost identical. Because of the
highly similar structural properties, our proposed model and that of
Han et al. are alike.
In conclusion, all three models suggest that the N terminus from
residues 2-11 exhibits a stable
-helix structure and that the
fusion peptide possesses a higher helical content at acidic pH
(fusogenic pH) than at neutral pH. Our E5 analog and the reported native fusion peptide NMR structures all showed a structural change in
the C-terminal helix at different pH values. However, the importance of
the hinge in the middle of the sequence and the C-terminal helix of HA2
fusion peptide in membrane fusion have not been reported before. In
this work, our NMR data of G13L and L17A, as described above, directly
demonstrate the importance of the hinge in
Gly12-Gly13 and the C-terminal
310-helix in Trp14-Ile18 in fusion
activity. It is known that the E5 analog and the native fusion peptide
of influenza HA2 induce fusion activity at acidic pH and possess
similar characteristics when interacting with the lipid bilayer. Most
interestingly, we found that the structure/fusion activity
relationships exhibited by the E5 analog represent well the property of
the native fusion peptide of influenza virus HA2. Consequently, our
model further provides insight into the mechanism of membrane fusion
for influenza virus HA2 fusion peptide.
 |
ACKNOWLEDGEMENT |
We thank Shu-Fang Cheng for performing
acrylamide quenching experiments.
 |
FOOTNOTES |
*
This work was supported by National Science Council Grants
NSC-89-2113-M-001-015 (to C. C.) and NSC-90-2320-B-001-047 and NSC-89-2316-B-001-018 (to S. H. W.) and by funds from
Academia Sinica.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence may be addressed: Inst. of
Biological Chemistry, Academia Sinica, Taipei 115, Taiwan. Tel.:
886-2-2785-5696, Ext. 7101; Fax: 886-2-2653-9142; E-mail:
shwu@gate.sinica.edu.tw.

To whom correspondence may be addressed: Inst. of Biomedical
Sciences, Academia Sinica, Taipei 115, Taiwan. Tel.:
886-2-2652-3035; Fax: 886-2-2788-7641; E-mail:
bmchinp@ccvax.sinica.edu.tw.
Published, JBC Papers in Press, April 5, 2002, DOI 10.1074/jbc.M200089200
 |
ABBREVIATIONS |
The abbreviations used are:
HA, hemagglutinin;
BHA, bromelain-solubilized hemagglutinin ectodomain;
TBHA2, a proteolytic fragment of the low-pH form of BHA;
DPC, dodecylphosphocholine;
NOE, nuclear Overhauser enhancement;
NOESY, NOE
spectroscopy.
 |
REFERENCES |
| 1.
|
Skehel, J. J.,
Bayley, P. M.,
Brown, E. B.,
Martin, S. R.,
Waterfield, M. D.,
White, J. M.,
Wilson, I. A.,
and Wiley, D. C.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
968-972[Abstract/Free Full Text]
|
| 2.
|
White, J.,
Kartenbeck, J.,
and Helenius, A.
(1982)
EMBO J.
1,
217-222[Medline]
[Order article via Infotrieve]
|
| 3.
|
Wharton, S. A.,
Skehel, J. J.,
and Wiley, D. C.
(1986)
Virology
149,
27-35[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
van Meer, G.,
Davoust, J.,
and Simons, K.
(1985)
Biochemistry
24,
3593-3602[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Macosko, J. C.,
Kim, C. H.,
and Shin, Y. K.
(1997)
J. Mol. Biol.
267,
1139-1148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Haywood, A. M.,
and Boyer, B. P.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
4611-4615[Abstract/Free Full Text]
|
| 7.
|
Midoux, P.,
Mayer, R.,
and Monsigny, M.
(1995)
Biochim. Biophys. Acta
1239,
249-256[Medline]
[Order article via Infotrieve]
|
| 8.
|
Luneberg, J.,
Martin, I.,
Nussler, F.,
Ruysschaert, J. M.,
and Herrmann, A.
(1995)
J. Biol. Chem.
270,
27606-27614[Abstract/Free Full Text]
|
| 9.
|
Wilson, I. A.,
Skehel, J. J.,
and Wiley, D. C.
(1981)
Nature
289,
366-373[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Bullough, P. A.,
Hughson, F. M.,
Skehel, J. J.,
and Wiley, D. C.
(1994)
Nature
371,
37-43[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Barker, W. C.,
Garavelli, J. S.,
Haft, D. H.,
Hunt, L. T.,
Marzec, C. R.,
Orcutt, B. C.,
Srinivasarao, G. Y.,
Yeh, L. S. L.,
Ledley, R. S.,
Mewes, H. W.,
Pfeiffer, F.,
and Tsugita, A.
(1998)
Nucleic Acids Res.
26,
27-32[Abstract/Free Full Text]
|
| 12.
|
Matsumoto, T.
(1999)
Biophys. Chem.
79,
153-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Lear, J. D.,
and DeGrado, W. F.
(1987)
J. Biol. Chem.
262,
6500-6505[Abstract/Free Full Text]
|
| 14.
|
Murata, M.,
Takahashi, S.,
Shirai, Y.,
Kagiwada, S.,
Hishida, R.,
and Ohnishi, S.
(1993)
Biophys. J.
64,
724-734[Abstract/Free Full Text]
|
| 15.
|
Gething, M. J.,
Doms, R. W.,
York, D.,
and White, J.
(1986)
J. Cell Biol.
102,
11-23[Abstract/Free Full Text]
|
| 16.
|
Steinhauer, D. A.,
Wharton, S. A.,
Skehel, J. J.,
and Wiley, D. C.
(1995)
J. Virol.
69,
6643-6651[Abstract]
|
| 17.
|
Han, X.,
Steinhauer, D. A.,
Wharton, S. A.,
and Tamm, L. K.
(1999)
Biochemistry
38,
15052-15059[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Murata, M.,
Takahashi, S.,
Kagiwada, S.,
Suzuki, A.,
and Ohnishi, S.
(1992)
Biochemistry
31,
1986-1992[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Pichon, C.,
Freulon, I.,
Midoux, P.,
Mayer, R.,
Monsigny, M.,
and Roche, A. C.
(1997)
Antisense Nucleic Acid Drug Dev.
7,
335-343[Medline]
[Order article via Infotrieve]
|
| 20.
|
Brasseur, R.,
Vandenbranden, M.,
Cornet, B.,
Burny, A.,
and Ruysschaert, J. M.
(1990)
Biochim. Biophys. Acta
1029,
267-273[Medline]
[Order article via Infotrieve]
|
| 21.
|
Takahashi, S.
(1990)
Biochemistry
29,
6257-6264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Han, X.,
Bushweller, J. H.,
Cafiso, D. S.,
and Tamm, L. K.
(2001)
Nat. Struct. Biol.
8,
715-720[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Dubovskii, P. V., Li, H.,
Takahashi, S.,
Arseniev, A. S.,
and Akasaka, K.
(2000)
Protein Sci.
9,
786-798[Abstract]
|
| 24.
|
Sreerama, N.,
and Woody, R. W.
(1993)
Anal. Biochem.
209,
32-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Lakowicz, J. R.
(1983)
Principles of Fluorescence Spectroscopy
, Plenum Press, New York
|
| 26.
|
Rance, M.,
Sorensen, O. W.,
Bodenhausen, G.,
Wagner, G.,
Ernst, R. R.,
and Wüthrich, K.
(1983)
Biochem. Biophys. Res. Commun.
117,
479-485[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Bax, A.,
and Davis, D. G.
(1985)
J. Magn. Reson.
65,
355-360
|
| 28.
|
Kumar, A.,
Ernst, R. R.,
and Wüthrich, K.
(1980)
Biochem. Biophys. Res. Commun.
95,
1-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Marion, D.,
and Wüthrich, K.
(1983)
Biochem. Biophys. Res. Commun.
113,
967-974[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Piotto, M.,
Saudek, V.,
and Sklenar, V.
(1992)
J. Biomol. NMR
2,
661-665[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Brunger, A. T.
(1998)
X-PLOR
, Yale University Press, New Haven, CT
|
| 32.
|
Koradi, R.,
Billeter, M.,
and Wüthrich, K.
(1996)
J. Mol. Graph.
14,
29-32
|
| 33.
|
Nicholls, A.,
Sharp, K. A.,
and Honig, B.
(1991)
Proteins Struct. Funct. Genet.
11,
281-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Laskowski, R. A.,
Rullmannn, J. A.,
MacArthur, M. W.,
Kaptein, R.,
and Thornton, J. M.
(1996)
J. Biomol. NMR
8,
477-486[Medline]
[Order article via Infotrieve]
|
| 35.
|
Creighton, T. E.
(1993)
Proteins
, pp. 190-191, Freeman, New York
|
| 36.
|
Rafalski, M.,
Ortiz, A.,
Rockwell, A.,
van Ginkel, L. C.,
Lear, J. D.,
DeGrado, W. F.,
and Wilschut, J.
(1991)
Biochemistry
30,
10211-10220[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit